Insmed has a performance score of 4 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.4433, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Insmed returns are expected to increase less than the market. However, during the bear market, the loss on holding Insmed will be expected to be smaller as well. By evaluating Insmed Inc technical indicators, you can presently evaluate if the expected return of 0.16% will be sustainable into the future. Insmed Inc right now retains a risk of 2.88%. Please check out Insmed variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Insmed will be following its current trending patterns.
4 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Insmed Inc are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Insmed may actually be approaching a critical reversion point that can send shares even higher in December 2023. ...more
Forward Dividend Yield
Last Split Factor
Last Split Date
|Insmed A Hidden Gem or Just Modestly Undervalued|
|Insmed To Present at the Morgan Stanley 21st Annual Global Healthcare Conference|
|Myotonic Dystrophy Pipeline, Clinical Trials Assessment, and FDA Approvals 2023 - Benzinga|
|Adult severe asthma registries POR - Dove Medical Press|
|Soleno Therapeutics Provides Corporate Update and Reports Third ... - StreetInsider.com|
|Begin Period Cash Flow||716.8 M|
|Total Cashflows From Investing Activities||-34.6 M|
Insmed Relative Risk vs. Return LandscapeIf you would invest 2,208 in Insmed Inc on August 30, 2023 and sell it today you would earn a total of 170.00 from holding Insmed Inc or generate 7.7% return on investment over 90 days. Insmed Inc is currently generating 0.1568% in daily expected returns and assumes 2.8837% risk (volatility on return distribution) over the 90 days horizon. In different words, 25% of stocks are less volatile than Insmed, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Given the investment horizon of 90 days Insmed is expected to generate 3.68 times more return on investment than the market. However, the company is 3.68 times more volatile than its market benchmark. It trades about 0.05 of its potential returns per unit of risk. The NYSE Composite is currently generating roughly -0.01 per unit of risk.
Insmed Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Insmed's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Insmed Inc, and traders can use it to determine the average amount a Insmed's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Insmed Fundamentals Growth
Insmed Stock prices reflect investors' perceptions of the future prospects and financial health of Insmed, and Insmed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Insmed Stock performance.
About Insmed Performance
Things to note about Insmed Inc performance evaluationChecking the ongoing alerts about Insmed for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Insmed Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions. Evaluating Insmed's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Insmed's stock performance include:
- Analyzing Insmed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Insmed's stock is overvalued or undervalued compared to its peers.
- Examining Insmed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Insmed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Insmed's management team can help you assess the company's leadership.
- Pay attention to analyst opinions and ratings of Insmed's stock. These opinions can provide insight into Insmed's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Insmed Stock analysis
When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.